Baskett Forest (CIK 0001277631)

Latest company ownership

Shares held
82,978,668
Last filed at
Jan 28, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Role: 10% Owner
Shares held
24,471,264
Last filed at
Jul 19, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4
Role: 10% Owner
Shares held
13,161,963
Last filed at
Nov 13, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
10,421,428
Last filed at
Apr 13, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Shares held
4,659,333
Last filed at
Aug 29, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2010Q2 2025Q4
Shares held
3,580,877
Last filed at
Jan 15, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4
Role: 10% Owner
Shares held
3,401,499
Last filed at
Mar 14, 2025
Confidence Score
49.4
2025Q4
Confidence Score History
2025Q1 2025Q4
Shares held
2,927,708
Last filed at
Oct 10, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Role: 10% Owner
Shares held
2,922,773
Last filed at
Oct 6, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
Role: 10% Owner
Shares held
2,724,202
Last filed at
Feb 15, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
2,611,050
Last filed at
Apr 7, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Role: 10% Owner
Shares held
2,258,850
Last filed at
Dec 27, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4
Role: 10% Owner
Shares held
2,091,383
Last filed at
Sep 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
1,989,872
Last filed at
Apr 15, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Role: 10% Owner
Shares held
1,712,810
Last filed at
Jul 16, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
1,625,678
Last filed at
Dec 23, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2021Q1 2025Q4
Role: 10% Owner
Shares held
1,090,793
Last filed at
Apr 24, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q2 2025Q4
Shares held
859,375
Last filed at
Mar 10, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
669,002
Last filed at
Jun 30, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Role: Director
Shares held
509,780
Last filed at
Oct 6, 2025
Confidence Score
32.2
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
267,935
Last filed at
Nov 12, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
212,650
Last filed at
Nov 12, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
36,688
Last filed at
May 4, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4
Role: 10% Owner
Shares held
33,234
Last filed at
Nov 17, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
11,300
Last filed at
Jan 31, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4
Role: 10% Owner
Shares held
9,525
Last filed at
Nov 18, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4
Shares held
1,602
Last filed at
Sep 16, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
Shares held
1,548
Last filed at
Jun 15, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Role: 10% Owner
Shares held
0
Last filed at
Dec 22, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4
Shares held
0
Last filed at
Feb 27, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 2, 2025 Oct 6, 2025 NeueHealth, Inc. Director Sell 26.3 -3,840,816 -36.79% $15.6K
Mar 12, 2025 Mar 14, 2025 BuzzFeed, Inc. 10% Owner Sell 20.0 -362,966 -9.64% $798K
Mar 7, 2025 Mar 11, 2025 BuzzFeed, Inc. 10% Owner Sell 22.5 -47,477 -1.25% $96.2K
Mar 4, 2025 Mar 6, 2025 BuzzFeed, Inc. 10% Owner Sell 36.3 -21,531 -0.56% $44.6K
Dec 23, 2024 Dec 23, 2024 Marker Therapeutics, Inc. 10% Owner Buy 100.0 +554,250 51.73% $1.8M
Sep 16, 2024 Sep 17, 2024 MBX Biosciences, Inc. 10% Owner Buy 100.0 +500,000 16.05% $8M
Apr 22, 2024 Apr 24, 2024 Korro Bio, Inc. 10% Owner Buy 85.0 +17,857 1.66% $1000K
Jul 18, 2023 Jul 20, 2023 Sagimet Biosciences Inc. 10% Owner Buy 67.5 +29,338 0.38% $469.4K
Jul 17, 2023 Jul 19, 2023 Savara Inc 10% Owner Buy 85.0 +333,333 1.38% $1000K
Dec 20, 2022 Dec 22, 2022 Arcellx, Inc. 10% Owner Sell 22.5 -2,000,000 -29.65% $51.2K
Jun 21, 2022 Jun 23, 2022 Arcellx, Inc. 10% Owner Buy 93.8 +312,500 4.86% $5M
May 26, 2022 May 31, 2022 IonQ, Inc. 10% Owner Sell 15.0 -2,922,966 -10.00% $17.1M
Apr 11, 2022 Apr 13, 2022 Trevi Therapeutics, Inc. 10% Owner Buy 100.0 +2,631,578 33.78% $5M
Apr 5, 2022 Apr 7, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 20.0 -694,551 -21.01% $751.3K
Feb 8, 2022 Feb 9, 2022 Arcellx, Inc. 10% Owner Buy 100.0 +1,583,333 32.65% $23.7M
Jan 28, 2022 Feb 1, 2022 Robinhood Markets, Inc. Director Sell 26.3 -23,847,593 -33.35% $29.6K
Jan 21, 2022 Jan 25, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 22.5 -134,558 -3.91% $202.2K
Jan 18, 2022 Jan 20, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 36.3 -26,555 -0.77% $48.7K
Jan 12, 2022 Jan 14, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 36.3 -21,550 -0.62% $41.8K
Jan 7, 2022 Jan 11, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 36.3 -18,760 -0.53% $38.7K
Jan 4, 2022 Jan 6, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 32.5 -31,916 -0.90% $72.2K
Dec 30, 2021 Jan 3, 2022 Enliven Therapeutics, Inc. 10% Owner Sell 20.0 -116,476 -3.19% $266.9K
Dec 27, 2021 Dec 29, 2021 Enliven Therapeutics, Inc. 10% Owner Sell 22.5 -67,427 -1.81% $159.5K
Dec 9, 2021 Dec 27, 2021 ARDELYX, INC. 10% Owner Sell 17.5 -2,881,570 -21.14% $3.6M
Dec 9, 2021 Dec 27, 2021 Enliven Therapeutics, Inc. 10% Owner Sell 20.0 -291,152 -7.25% $688.5K
Jun 28, 2021 Jun 30, 2021 NeueHealth, Inc. 10% Owner Buy 95.0 +1,944,444 2.78% $35M
Jun 28, 2021 Jun 30, 2021 Monte Rosa Therapeutics, Inc. 10% Owner Buy 100.0 +1,050,000 15.81% $20M
Apr 13, 2021 Apr 15, 2021 OnKure Therapeutics, Inc. 10% Owner Buy 100.0 +666,666 16.19% $10M
Mar 16, 2021 Mar 18, 2021 Marker Therapeutics, Inc. 10% Owner Buy 100.0 +5,714,285 114.29% $10M
Nov 11, 2020 Nov 13, 2020 Cloudflare, Inc. 10% Owner Sell 17.5 -12,133,330 -75.95% $1.3M
Aug 19, 2020 Aug 21, 2020 Cloudflare, Inc. 10% Owner Sell 15.0 -456,796 -13.97% $17.6M
Aug 14, 2020 Aug 18, 2020 Cloudflare, Inc. 10% Owner Sell 15.0 -410,700 -11.16% $16.2M
Aug 17, 2020 Aug 18, 2020 Sprout Social, Inc. 10% Owner Sell 15.0 -3,441,846 -38.14% $94.7M
Aug 11, 2020 Aug 13, 2020 Cloudflare, Inc. 10% Owner Sell 15.0 -738,278 -16.71% $28.4M
Aug 7, 2020 Aug 10, 2020 Cloudflare, Inc. 10% Owner Sell 17.5 -19,473,349 -81.50% $3.4M
Jul 14, 2020 Jul 16, 2020 Nkarta, Inc. 10% Owner Buy 100.0 +666,666 29.82% $12M
Jun 15, 2020 Jun 17, 2020 ARDELYX, INC. 10% Owner Sell 52.5 -43 0.00% $273.9
Jun 10, 2020 Jun 12, 2020 ARDELYX, INC. 10% Owner Sell 20.0 -2,499,957 -15.50% $719K
May 19, 2020 May 21, 2020 Cloudflare, Inc. 10% Owner Sell 16.3 -5,194,802 -55.71% $9.6M
Apr 13, 2020 Apr 14, 2020 Mersana Therapeutics, Inc. 10% Owner Sell 51.3 -3,190 -0.04% $27.4K
Apr 3, 2020 Apr 13, 2020 Trevi Therapeutics, Inc. 10% Owner Sell 52.5 -564 -0.01% $1.5K
Apr 9, 2020 Apr 13, 2020 Mersana Therapeutics, Inc. 10% Owner Sell 22.5 -3,996,810 -33.42% $177.8K
Aug 28, 2019 Apr 13, 2020 Mersana Therapeutics, Inc. 10% Owner Sell 52.5 -1,211 -0.01% $3.5K
Mar 16, 2020 Mar 16, 2020 Enliven Therapeutics, Inc. 10% Owner Buy 100.0 +475,000 13.42% $7.6M
Mar 6, 2020 Mar 10, 2020 CHAMPIONS ONCOLOGY, INC. 10% Owner Sell 17.5 -708,155 -29.24% $5M
Jan 24, 2020 Jan 28, 2020 Adaptimmune Therapeutics PLC 10% Owner Buy 96.3 +7,500,000 7.90% $5M
Nov 12, 2019 Nov 12, 2019 Galera Therapeutics, Inc. 10% Owner Buy 100.0 +416,666 10.57% $5M
Jul 22, 2019 Jul 24, 2019 Mirum Pharmaceuticals, Inc. 10% Owner Buy 100.0 +450,000 12.04% $6.8M
May 9, 2019 May 13, 2019 Trevi Therapeutics, Inc. 10% Owner Buy 100.0 +2,500,000 128.96% $25M
Mar 5, 2019 Mar 6, 2019 Mersana Therapeutics, Inc. 10% Owner Buy 100.0 +3,750,000 46.07% $15M
Sep 7, 2018 Sep 10, 2018 Adaptimmune Therapeutics PLC 10% Owner Buy 100.0 +15,000,000 18.76% $25M
Mar 26, 2018 Mar 28, 2018 Adaptimmune Therapeutics PLC 10% Owner Buy 97.5 +6,571,164 8.95% $12.6M
Mar 21, 2018 Mar 23, 2018 Adaptimmune Therapeutics PLC 10% Owner Buy 87.5 +1,268,508 1.76% $2.4M
Feb 26, 2018 Feb 27, 2018 Oruka Therapeutics, Inc. 10% Owner Sell 20.0 -1,460,209 -100.00% $731.3K
Nov 27, 2017 Nov 27, 2017 APPIAN CORP 10% Owner Sell 15.0 -569,620 -100.00% $11.1M
Nov 20, 2017 Nov 21, 2017 APPIAN CORP 10% Owner Sell 15.0 -2,820,516 -100.00% $55M
Oct 10, 2017 Oct 10, 2017 RHYTHM PHARMACEUTICALS, INC. 10% Owner Buy 100.0 +550,000 12.61% $9.4M
Aug 30, 2017 Aug 31, 2017 ARDELYX, INC. 10% Owner Sell 52.5 -485 0.00% $2.4K
Jul 3, 2017 Jul 6, 2017 Mersana Therapeutics, Inc. 10% Owner Buy 100.0 +1,000,000 14.01% $15M
Mar 27, 2017 Mar 28, 2017 Adaptimmune Therapeutics PLC 10% Owner Buy 100.0 +12,870,000 21.71% $9M
Jul 18, 2016 Jul 20, 2016 ARDELYX, INC. 10% Owner Buy 100.0 +2,290,951 19.43% $20M
Jan 13, 2016 Jan 14, 2016 ARDELYX, INC. 10% Owner Buy 100.0 +1,500,000 14.57% $15M
Oct 5, 2015 Oct 6, 2015 SYNLOGIC, INC. 10% Owner Buy 100.0 +1,146,308 21.08% $6M
Jun 17, 2015 Jun 19, 2015 SUPERNUS PHARMACEUTICALS, INC. 10% Owner Sell 17.5 -111,881 -1.44% $1.8M
Jun 15, 2015 Jun 17, 2015 SUPERNUS PHARMACEUTICALS, INC. 10% Owner Sell 17.5 -2,888,119 -27.14% $1.9M
Jun 5, 2015 Jun 9, 2015 ARDELYX, INC. 10% Owner Buy 100.0 +4,672,897 83.14% $50M
Dec 23, 2014 Dec 29, 2014 ARDELYX, INC. 10% Owner Sell 51.3 -9,515 -0.17% $42K
Aug 27, 2014 Aug 29, 2014 Viracta Therapeutics, Inc. 10% Owner Sell 17.5 -266,700 -5.41% $2.1M
Aug 8, 2014 Aug 12, 2014 Viracta Therapeutics, Inc. 10% Owner Sell 17.5 -710,540 -12.61% $4.7M
Jan 15, 2014 Jan 15, 2014 CRESCENT BIOPHARMA, INC. 10% Owner Buy 100.0 +512,500 14.31% $4.1M
Jun 30, 2010 Jul 2, 2010 Viracta Therapeutics, Inc. 10% Owner Buy 100.0 +23,824,451 100.00% $6.6M